Abstract
This review presents information on cases of antibiotic failure (insufficient effect) in the global population over the past three years. We analyzed scientific papers, clinical trial data, and the WHO Program for International Drug Monitoring (VigiBase) data from 2018 to 2020. The values of global success and safety rates of antibacterial drugs for medical use are presented. The findings may be of practical interest to physicians, researchers, developers, and healthcare regulators.
Reference14 articles.
1. Evteev VA, Muslimova OV, Mazerkina IA, et al. Organic anion transporters and their influence on the toxicity of β-lactam antibiotics. Bezopasnost' i risk farmakoterapii. 2017;5(2):70–75. (In Russ).
2. Fluoroquinolone antibiotics: safety of use by the example of ciprofloxacin
3. Ortenberg EA, Khokhlyavina RM, Shpil'kina LV, Khokhlyavin RL. Local antibiotic resistance in a multidisciplinary state: is an annual assessment sufficient? Ural'skii meditsinskii zhurnal. 2007;(6):54–58. (In Russ).
4. Drug-Induced Neutropenia and Agranulocytosis
5. Drug-Induced Eosinophilia